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Beckwith-Wiedeman syndrome (BWS) and Klippel-Trenaunay-Weber syndrome (KTWS) are different human dis-
orders characterized, among other features, by tissue overgrowth. Deregulation of one or more imprinted genes
located at chromosome 11p15.5, of which insulin-like growth factor 2 (IGF2) is the most likely candidate, is
believed to cause BWS, whereas the etiology of KTWS is completely obscure. We report a case of BWS and a case
of KTWS in a single family. The probands, sons of two sisters, showed relaxation of the maternal IGF2 imprinting,
although they inherited different 11p15.5 alleles from their mothers and did not show any chromosome rearrange-
ment. The patient with BWS also displayed hypomethylation at KvDMR1, a maternally methylated CpG island
within an intron of the KvLQT1 gene. The unaffected brother of the BWS proband shared the same maternal and
paternal 11p15.5 haplotype with his brother, but the KvDMR1 locus was normally methylated. Methylation of
the H19 gene was normal in both the BWS and KTWS probands. Linkage between the insulin-like growth factor
2 receptor (IGF2R) gene and the tissue overgrowth was also excluded. These results raise the possibility that a
defective modifier or regulatory gene unlinked to 11p15.5 caused a spectrum of epigenetic alterations in the germ
line or early development of both cousins, ranging from the relaxation of IGF2 imprinting in the KTWS proband
to disruption of both the imprinted expression of IGF2 and the imprinted methylation of KvDMR1 in the BWS
proband. Analysis of these data also indicates that loss of IGF2 imprinting is not necessarily linked to alteration
of methylation at the KvDMR1 or H19 loci and supports the notion that IGF2 overexpression is involved in the
etiology of the tissue hypertrophy observed in different overgrowth disorders, including KTWS.
Introduction
The molecular mechanisms underlying human syn-
dromes associated with overgrowth, apart from specific
hormone disorders, are largely unknown (Weaver 1994).
Most of the available data derive from studies on Beck-
with-Wiedemann syndrome (BWS [MIM 130650]), a
disease characterized by generalized or regional over-
growth, macroglossia, and abdominal wall defects, as
well as a predisposition to embryonal tumors. One or
more imprinted genes located at 11p15.5 are likely to
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be responsible for BWS (Li et al. 1997; Reik and Maher
1997). Genomic imprinting is a mechanism that causes
the expression of a gene to be dependent on the gametic
origin (Tilghman 1999). Evidences of its involvement in
the determination of BWS include uniparental paternal
disomy of chromosome 11p15, duplication of the pa-
ternally derived 11p15.5, relaxation of imprinting of the
insulin-like growth factor 2 (IGF2) gene, and translo-
cations of maternal chromosome 11 with breakpoint in
11p15.4-15.5 in sporadic cases of BWS. In addition,
linkage to 11p15.5 with increased penetrance associated
with maternal transmission is observed in the rarer fa-
milial cases (Li et al. 1997; Reik andMaher 1997). Since
IGF2 is normally transcribed only from the paternally
inherited allele, overexpression of this gene might rep-
resent the endpoint of the majority of BWS molecular
alterations. IGF-II, the peptide encoded by the IGF2
gene, is a broad-spectrum mitogen with an important
role in the control of prenatal growth, as demonstrated
in mice with gene disruption and growth retardation, or
in animals expressing high levels of this growth factor
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and showing somatic overgrowth at birth (De Chiara et
al. 1990; Leighton et al. 1995; Eggenschwiler et al. 1997;
Sun et al. 1997). For these reasons, IGF2 overexpression
could be responsible for the tissue hypertrophy observed
in BWS. Consistent with this hypothesis, Wilms tumor,
rhabdomyosarcoma, and hepatoblastoma, which are
frequently associated with BWS, show high levels of
IGF2 mRNA as well as similar genetic and epigenetic
defects related to the 11p15 region (Toretsky and Hel-
man 1996). However, alteration of other linked im-
printed genes may contribute to some of the symptoms
of BWS (Reik and Maher 1997).
Altered DNAmethylation at two loci of chromosome
11p15.5 has frequently been observed in patients with
BWS (Joyce et al. 1997; Lee et al. 1999; Smilinich et
al. 1999); 5%–10% of patients with BWS show hy-
permethylation and silencing of the otherwise activema-
ternal allele of the H19 gene. These individuals also
display biallelic IGF2 expression, consistent with the
hypothesis that the linked IGF2 andH19 genes compete
for the same enhancer elements (Reik andMaher 1997).
More frequent (30%–50%) is the demethylation of the
maternally inherited copy of KvDMR1, a CpG island
included in an intron of the paternally imprinted
KvLQT1 gene, a locus located 350 Kb centromeric to
IGF2 (Lee et al. 1999; Smilinich et al. 1999). This ep-
igenetic alteration, the significance of which is still un-
defined in the BWS pathogenesis, has been found to be
associated with biallelic expression of a maternally im-
printed gene (KvLQT1-AS or LIT1) transcribed in the
antisense orientation with respect to KvLQT1 (Lee et
al. 1999). A subset of BWS cases with KvDMR1 hy-
pomethylation have loss of IGF2 imprinting, but each
of the two epigenetic lesions has also been found in-
dividually (Lee et al. 1999; Smilinich et al. 1999).
IGF-II turnover is controlled by binding to the
membrane-associated type II–IGF receptor (Rechler and
Nissley 1990). In a minority of human individuals, the
IGF2R gene is subjected to genomic imprinting, since
only the maternal allele is expressed (Xu et al. 1993).
Mice deficient in Igf2r activity have elevated levels of
circulating IGF-II and are 25%–30% larger than their
normal sibs, raising the possibility that individuals who
have monoallelic expression of this gene may have in-
creased susceptibility to overgrowth disorders and ma-
lignancy (Lau et al. 1994).
Klippel-Trenaunay-Weber syndrome (KTWS [MIM
149000]) is a disease of unknown etiology characterized
by cutaneous hemangiomata and regional hypertrophy
of bones and soft tissues. In this article, we describe a
family in which two first cousins are affected, one by
BWS and one by KTWS, and we provide evidence of
partially overlapping epigenetic alterations in the two
patients. The results indicate a link between the molec-
ular defects leading to BWS and to KTWS and provide




The BWS proband was diagnosed on the basis of the
presence of hypoglycemia, exomphalos, and macroglos-
sia. Clinical evaluation of the boy at 6 years of age re-
vealed weight and height at the 90th–95th percentile,
mild right hemihypertrophy, and hepatosplenomegaly.
Analysis of ultrascan showed enlargement of the pan-
creas and kidneys at the upper limits of the normal
range. Neither ear lobe grooves nor circular depressions
of posterior helices were observed. The other described
patient with BWS (BWS2) was macrosomic at birth and
had visceromegaly and macroglossia. Clinical exami-
nation of the boy at 1 year of age also revealed left
hemihypertrophy and bilateral Wilms tumor.
At 32 weeks of gestation, the KTWS proband pre-
sented with hydrothorax, which required intrauterine
thoracentesis. At birth, diffuse capillary hemangiomata
and hemihypertrophy of the left side were observed.
Clinical evaluation of the boy at age 7 years indicated
that weight and height were in the 75th percentile. We
also observed marked hemihypertrophy of both bone
and soft tissues of the left side, including the left side of
the tongue and the maxillary bone, and diffuse heman-
giomata on both sides. No visceromegaly was found by
ultrasound examination. The presence of arterovenous
fistulae was ruled out.
Cell Cultures
Cultured skin fibroblasts were obtained by means of
a punch biopsy and established by standard techniques.
Cells used for the analysis of allele-specific expression
were of low passage number (!10th generation).
Isolation of DNA and RNA
Genomic DNA from blood leukocytes and cultured
skin fibroblasts was prepared by SDS–proteinase K di-
gestion and phenol-chloroform extraction methods. To-
tal RNA was purified from cells by the single-step acid
guanidinium thiocyanate-phenol-chloroform extraction
method (Chomczynski and Sacchi 1987) and further
treated for 30 min with 1 U of RQ RNase-free DNase
(Promega) at 37C in the presence of 40 mM Tris-HCl,
pH 7.6, 10 mM NaCl, 6 mM MgCl2, and 100 mM
CaCl2.
Allelic Analysis
The ApaI restriction fragment–length polymorphism
(RFLP) of the IGF2 gene was analyzed by PCR and
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Figure 1 Relaxation of IGF2 imprinting in the related BWS and KTWS patients. IGF2 alleles were analyzed by PCR and RT-PCR in
DNA and RNA extracted from cultured skin fibroblasts derived from the BWS (III-I) and KTWS (III-3) patients and a control individual by
means of primers specific for the ApaI RFLP. Fibroblasts derived from the larger (L) and smaller (S) sides of the bodies were analyzed. The
ApaI RFLP was typed with the ApaI (a) and AvaII (b) restriction enzymes. For the ApaI RFLP, the allele uncut by ApaI and cut by AvaII is
indicated with the letter A, and the allele cut by ApaI and uncut by AvaII is indicated with the letter B. RNA was tested with (RT) and
without (RT) addition of RT to check for contamination by genomic DNA.
reverse transcriptase (RT)–PCR as described elsewhere
(Pedone et al. 1994), except for the addition of a[32P]-
dATP to the reaction mixture. The ApaI RFLP was also
typed with the AvaII restriction enzyme. The 5′ and 3′
parts of the variable number of tandem-repeated DNA
sequences (VNTR) present in the IGF2 gene were an-
alyzed after labeling of the sense or antisense primer,
respectively, and after digestion of the amplification
product with BstUI (Rainier et al. 1993). The VNTR of
the tyrosine hydroxylase gene (TH) and the H19 RsaI
and AluI RFLPs were typed as described elsewhere, with
the addition of a[32P]-dATP to the reaction mixture (Ed-
wards et al. 1991; Casola et al. 1997). The VNTR of
the 3′ UTR of the IGF-2R gene was typed as described
by Hol et al. (1992) by end labeling one of the primers.
All RNA samples were run in duplicate with or without
addition of RT to control for contamination by genomic
DNA. Alleles were quantified by computer analysis of
the image by a Molecular Dynamics phosphorimager.
Methylation Analysis
High–molecular-weight DNA extracted from blood
leukocytes was digested with methylation-sensitive re-
striction enzymes, blotted, and hybridized to a[32P]-la-
beled probes specific for the H19 5′ flanking and
KvLQT1 intron 10 differentially methylated region
(DMRP), as described elsewhere (Morison et al. 1996;
Smilinich et al. 1999). The H19 probe was a PCR frag-
ment generated from human genomic DNA with the
primers 5′-ACTCTGTCCTGCGGAAACCG-3′ and 5′-
GGAGACAGGGCTGAGCATTG-3′ and cloned into
pGEM4Z (Promega). The probes were [32P]-labeled by
random priming (Feinberg and Vogelstein 1984). Bands
were quantified by analysis of the image by a Molecular
Dynamics phosphorimager.
Chromosome Analysis
High-resolution chromosome analysis (600–650
bands) was performed according to the procedure re-
ported by Gosden et al. (1982).
Results
The probands were two boys born to two sisters; one
was diagnosed with BWS and the other with KTWS at
birth. We analyzed the imprinting status of the IGF2
gene in their cultured skin fibroblasts. To distinguish the
paternal from the maternal allele, we checked to see
whether the findings were informative for theApaI RFLP
(Tadokoro et al. 1991) present in the 3′ UTR of the IGF2
gene. Since findings for both patients were informative
for this polymorphism, allele-specific expression was an-
alyzed by RT-PCR from RNA extracted from the cul-
tured skin fibroblasts (fig. 1). The ApaI RFLP can also
be typed with AvaII; the sequences recognized by the
two restriction enzymes are mutually exclusive in the
IGF2 alleles (Brown et al. 1996). PCR products were
therefore digested with both ApaI and AvaII, to avoid
misinterpretation of the results because of incomplete
digestion (fig. 1a and 1b). Results showed that both pa-
rental IGF2 alleles were expressed in cells derived from
the BWS (III-1) and the KTWS (III-3) patients (see fig.
2 for the pedigree). Since the patients showed hemihy-
pertrophy, skin biopsy specimens were obtained from
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Figure 2 Pedigree and genotypes of the analyzed family for six
11p15.5 markers.
different body regions. IGF2 expression from both pa-
rental alleles was observed in cells derived from both
the larger and smaller sides of the bodies of the two
patients (fig. 1a and 1b). In contrast, cells derived from
seven additional informative individuals whowere either
healthy or affected by unrelated pathologies and whose
cells were cultured under identical conditions showed
monoallelic expression of the IGF2 gene (fig. 1a and 1b;
lanes from control individuals and data not shown).
To assess whether the relaxation of IGF2 imprinting
status might be due to the inheritance of a genetic defect
linked to chromosome 11p15.5, we analyzed six poly-
morphic markers located in this region in the DNAs
extracted from peripheral blood leukocytes of the pa-
tients and their relatives (fig. 2). The resulting haplo-
types indicated that the BWS and KTWS patients in-
herited different alleles from their mothers at all loci
examined from the TH/H19 region of 11p15.5, thus
excluding a common genetic defect linked to this chro-
mosomal region. In addition, the same haplotype was
inherited by both the patient with BWS and his unaf-
fected brother. High-resolution chromosome analysis of
the patient’s fibroblasts was also performed and did not
reveal any rearrangement of the 11p and other chro-
mosomal regions (data not shown).
The methylation status of theH19 and KvDMR1 loci
was then investigated in the probands (fig. 3). For this
purpose, high–molecular-weight DNA was digested
with RsaI and the methylation-sensitive enzyme HpaII
and was then hybridized to a probe specific for theH19
5′ flanking or digested with EcoRI and the methylation-
sensitive enzyme NotI and hybridized to a probe
(DMRP) specific for the KvLQT1 intron 10, as de-
scribed elsewhere (Morison et al. 1996; Smilinich et al.
1999). As shown in figure 3a, the H19 promoter was
digested by HpaII at the same extent (∼50%) in the
samples derived from the probands (III-1 and III-3),
their unaffected brothers (III-2 and III-4), and an un-
related normal individual (C), indicating that the meth-
ylation of the H19 alleles was unaltered in these pa-
tients. In contrast, complete methylation of the H19
promoter was observed in an unrelated patient with
BWS (BWS2). Different results were obtained when the
KvDMR1 methylation was assayed in the two cousins
(fig. 3b). Only the BWS proband ( III-1) showed a com-
plete demethylation of theNotI site, whereas the patient
with KTWS (III-3) displayed a 47% methylation, in-
dicating that the demethylation of the maternal
KvDMR1 allele occurred only in the BWS proband. A
pattern of partial methylation (42%–48%) was ob-
served with the DNAs derived from the unaffected
brothers (III-2 and III-4), the parents of the BWS pro-
band (II-1 and II-2), and an unrelated normal individual
(C), although the BWS proband shared with his brother
the maternal and paternal haplotypes at 11p15.5 (fig.
2). Patient BWS2, who showed H19 hypermethylation,
had a normal methylation pattern at the KvDMR1 lo-
cus, consistent with results for other BWS cases reported
elsewhere (Smilinich et al. 1999).
We then investigated the inheritance of the IGF2R
alleles and their imprinting status in the probands and
their relatives by typing a VNTR present in the 3′ UTR
of this gene (Hol et al. 1992). IGF2R expression was
found to be biallelic in the cells derived from the patient
with KTWS, as well as two informative unrelated pa-
tients with BWS and two control individuals (fig. 4; data
not shown). Analysis of the BWS patient of the family
under study did not provide information about this
polymorphism. The analysis of the other family mem-
bers showed that the probands and the unaffected
brother of the patient with KTWS inherited the same
IGF2R allele from their mothers, thus excluding the
possibility that a defective maternal IGF2R allele could
have been inherited by the two cousins (fig. 4).
Discussion
This work describes two boys, first cousins, one affected
by BWS and the other by KTWS. Both showed relax-
ation of the imprinted expression of the IGF2 gene but
differed in the methylation status of the KvDMR1 locus.
The latter remained normal in the boy with KTWS but
was altered in the boy with BWS. The probands inherited
different alleles at the 11p15.5 loci we investigated, in-
dicating that a common genetic defect linked to this
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Figure 3 Demethylation of the KvDMR1 locus in the patient with BWS. The methylation status of theH19 promoter (a) and theKvDMR1
locus (b) was analyzed in the DNA extracted from peripheral blood leukocytes of the BWS (III-1) and KTWS (III-3) probands, their unaffected
brothers (III-2 and III-4), patient BWS2, and an unrelated normal individual (C). KvDMR1 methylation was also tested in the parents of the
BWS proband (II-1 and II-2). For this purpose, 10 mg of DNA was digested with RsaI and HpaII or RsaI and MspI and hybridized to the H19
probe or digested with EcoRI and NotI and hybridized to the DMRP probe. The 2.2- and 0.4-Kb bands correspond to the methylated paternal
and unmethylated maternal H19 alleles, and the 4.2- and 2.7-Kb bands correspond to the methylated maternal and unmethylated paternal
KvDMR1 alleles, respectively, in normal individuals.
chromosome region was unlikely. Allelic and imprinting
analysis also excluded involvement of the IGF-2R gene.
Relaxation or loss of IGF2 imprinting is a relatively
frequent finding in human cancer and BWS (Reik and
Maher 1997; Feinberg 1999). Expression of the IGF2
gene from both parental alleles has been observed in
skin biopsy specimens derived from both sides of the
body in BWS patients with hemihypertrophy, suggesting
that the epigenetic defect is constitutional in these in-
dividuals (Weksberg et al. 1993). This is consistent with
our findings. Apart from the observation that a BWS
patient carrying a maternally transmitted 11p15.5
translocation shows biallelic expression of the IGF2
gene, no other mutation has so far been associated with
loss of IGF2 imprinting (Brown et al. 1996). In mice,
Igf2 imprinting is disrupted by deletion of a region dif-
ferentially methylated on the two parental alleles and
located 5′ of the linked H19 gene (Thorvaldsen et al.
1998). No mutations of such regions have been iden-
tified in BWS or cancer (Reik and Maher 1997). How-
ever, hypermethylation of the 5′ flanking region of the
maternal H19 allele or demethylation of the KvDMR1
locus has been found in Wilms tumors and a subset of
BWS patients displaying loss of IGF2 imprinting, sug-
gesting that the relaxation of IGF2 imprinting may be
caused by an epigenetic alteration (Moulton et al. 1994;
Steenman et al. 1994; Taniguchi et al. 1995; Reik and
Maher 1997; Smilinich et al. 1999). Consistent with
this hypothesis, activation of the maternal IGF2 allele
was achieved by perturbation of DNA methylation or
histone acetylation with specific inhibitors in animals
or cultured cells (Hu et al. 1997, 1998; Pedone et al.
1999). It has been proposed that the demethylation of
the KvDMR1 locus is independent of IGF2 imprinting
but is linked to the imprinting of the LIT1 (orKvLQT1)
gene and possibly to the expression of other 11p15.5
genes involved in the pathogenesis of BWS (Lee et al.
1999). Our results are consistent with this hypothesis,
since they show that the relaxation of IGF2 imprinting
can occur in the absence of altered methylation at both
H19 and KvDMR1 loci. Our results also support the
notion that KvDMR1 demethylation is a BWS-specific
epigenetic lesion.
Very few molecular data are available on KTWS. In
a single case, a translocation with a breakpoint in the
11p15.1 region was found, raising the question of a
putative gene located on chromosome 11p involved in
the pathogenesis of this disease (Whelan et al. 1995).
Rare familial aggregation of KTWS cases has been re-
ported, and paradominant transmission was proposed
(Aelvoet et al. 1992; Happle 1993). This mechanism
would imply that a predisposing single-gene defect is
846 Am. J. Hum. Genet. 66:841–847, 2000
Figure 4 Genotypes of the family analyzed for the IGF2RVNTR
marker and allele-specific expression of the IGF2R gene in the patient
with KTWS. IGF2R alleles were analyzed by PCR and RT-PCR in
DNA extracted from blood leukocytes and in RNA derived from cul-
tured skin fibroblasts of the KTWS patient (III-3) by primers specific
for the IGF2R VNTR polymorphism. Fibroblasts derived from both
the larger (L) and smaller (S) sides of the body were analyzed. Two
alleles, indicated as A and B, were observed. The “shadow” bands of
the A and B alleles are an artifact commonly observed when dinucle-
otide-repeat polymorphisms are typed and are very likely due to
slipped-strand mispairing during PCR amplification (Hauge´ and Litt
1993).
dominantly inherited and that the disease develops only
after occurrence of a second somatic mutation. The find-
ing of relaxation of IGF2 imprinting suggests for the
first time that overexpression of this growth-factor gene
may be involved in the pathogenesis of this overgrowth
syndrome.
To our knowledge, there are no previous reports of
BWS and KTWS phenotypes in the same pedigree. In
the family we studied, BWS and KTWS may represent
the result of a clinical spectrum of somatic overgrowth
caused by partially overlapping epigenetic alterations,
ranging from relaxation of IGF2 imprinting to disrup-
tion of both the imprinted IGF2 expression and
KvDMR1methylation. Clinical features typical of BWS
may be secondary to demethylation of KvDMR1. Al-
though we cannot exclude the possibility that the BWS
and KTWS cases described were sporadic, the results
are more likely explained by the maternal inheritance
of a defective modifier or regulatory gene not linked to
11p15.5, which disrupted IGF2 imprinting in the germ
line or the early development of the two cousins and
possibly also caused the KvDMR1 demethylation in the
BWS proband. The present report, together with the
reports of the relaxation of IGF2 imprinting found in
several patients with BWS and four reported instances
of nonsyndromic somatic overgrowth, reinforces the hy-
pothesis of a general role of IGF2 overexpression in
various human diseases having tissue overgrowth as a
common feature (Morison et al. 1996).
Acknowledgments
We thank M. J. Higgins for providing the DMRP probe and
G. Condorelli for providing several strains of human skin fi-
broblasts. This work was partially supported by grants from
Associazione Italiana Ricerca sul Cancro (to A.R.), Telethon-
Italia (grant N. E. 599), and Ministero della Ricerca Scientifica
e Tecnologica (MURST) 60% (to A.R. and G.S.).
Electronic-Database Information
Accession numbers and URL for data in this article are as
follows:
Online Mendelian Inheritance in Man (OMIM): http://www
.ncbi.nlm.nih.gov/Omim (for BWS [MIM 130650] and
KTWS [MIM 149000])
References
Aelvoet GE, Jorens PG, Roelen LM (1992) Genetic aspects of
the Klippel-Trenaunay syndrome. Br J Dermatol 126:
603–607
Brown KW, Villar AJ, Bickmore W, Clayton-Smith J, Catch-
poole D, Maher ER, Reik W (1996) Imprinting mutation in
the Beckwith-Wiedemann syndrome leads to biallelic IGF2
expression through an H19-independent pathway. Hum
Mol Genet 5:2027–2032
Casola S, Pedone PV, Cavazzana AO, Basso G, Luksch R,
d’Amore ESG, Carli M, et al (1997) Expression and parental
imprinting of the H19 gene in human rhabdomyosarcoma.
Oncogene 14:1503–1510
Chomczynski P, Sacchi N (1987) Single-step method of RNA
isolation by acid guanidinium thiocyanate-phenol-chloro-
form extraction. Anal Biochem 162:156–159
De Chiara TM, Efstratiadis A, Robertson EJ (1990) A growth-
deficiency phenotype in heterozygous mice carrying an in-
sulin-like growth factor II gene disrupted by targeting. Na-
ture 345:78–80
Edwards A, Civitello A, Hammond HA, Caskey CT (1991)
DNA typing and genetic mapping with trimeric and tetra-
meric tandem repeats. Am J Hum Genet 49:746–756
Eggenschwiler J, Ludwig T, Fisher P, Leighton PA, Tilghman
SM, Efstratiadis A (1997) Mouse mutant embryos overex-
pressing IGF-II exhibit phenotypic features of the Beckwith-
Wiedemann and Simpson-Golabi-Behmel syndromes. Genes
Dev 11:3128–3142
Feinberg AP (1999) Imprinting of a genomic domain of 11p15
and loss of imprinting in cancer: an introduction. Cancer
Res 59:1743S–1746S
Feinberg AP, Vogelstein B (1984) A technique for radiolabell-
ing DNA restriction endonuclease fragments to high specific
activity. Anal Biochem 137:266–267
Gosden CM, Davidson C, Robertson M (1982) Lymphocyte
culture. In: Rooney DE, Czepulkowski BH (eds) Human
Sperandeo et al.: IGF2 in First Cousins 847
cytogenetics: a practical approach, 2d ed. Oxford University
Press, Oxford, pp 31–56
Happle R (1993) Klippel-Trenaunay syndrome: is it a para-
dominant trait? Br J Dermatol 128:465–466
Hauge´ XY, Litt M (1993) A study of the origin of “shadow
bands” seen when typing dinucleotide repeat polymor-
phisms by the PCR. Hum Mol Genet 2:411–415
Hol FA, Geurds MPA, Hamel BCJ, Mariman ECM (1992)
Improving the polymorphism content of the 3′ UTR of the
human IGF2R gene. Hum Mol Genet 1:347
Hu JF, Nguyen PH, Pham NV, Vu TH, Hoffman AR (1997)
Modulation of Igf2 genomic imprinting in mice induced by
5-azacytidine, an inhibitor of DNA methylation. Mol En-
docrinol 11:1891–1898
Hu JF, Oruganti H, Vu TH, Hoffman AR (1998) The role of
histone acetylation in the allelic expression of the imprinted
human insulin-like growth factor II gene. Biochem Biophys
Res Commun 251:403–408
Joyce JA, Lam WK, Catchpoole DJ, Jenks P, Reik W, Maher
ER, Schofield PN (1997) Imprinting of IGF2 and H19: lack
of reciprocity in sporadic Beckwith-Wiedemann syndrome.
Hum Mol Genet 6:1543–1548
Lau MM, Stewart CE, Liu Z, Bhatt H, Rotwein P, Stewart CL
(1994) Loss of the imprinted IGF2/cation-independentman-
nose 6-phosphate receptor results in fetal overgrowth and
perinatal lethality. Genes Dev 8:2953–2963
Lee MP, DeBaun MR, Mitsuya K, Galonek HL, Brandenburg
S, Oshimura M, Feinberg AP (1999) Loss of imprinting of
a paternally expressed transcript, with antisense orientation
to KvLQT1, occurs frequently in Beckwith-Wiedemann syn-
drome and is independent of insulin-like growth factor II
imprinting. Proc Natl Acad Sci USA 96:5203–5208
Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A,
Tilghmann SM (1995) Disruption of imprinting caused by
deletion of the H19 gene region in mice. Nature 375:34–39
Li M, Squire JA, Weksberg R (1997) Molecular genetics of
Beckwith-Wiedemann syndrome. Curr Opin Pediatr 9:
623–629
Morison IM, Becroft DM, Taniguchi T, Woods CG, Reeve AE
(1996). Somatic overgrowth associated with overexpression
of insulin-like growth factor II. Nat Med 2:311–316
Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N,
Dembitzer F, Hensle T, et al (1994) Epigenetic lesions at the
H19 locus in Wilms’ tumour patients. Nat Genet 7:440–447
Pedone PV, PikaartMJ, Cerrato F, VernucciM, Ungaro P, Bruni
CB, Riccio A (1999) Role of histone acetylation and DNA
methylation in the maintenance of the imprinted expression
of the H19 and Igf2 genes. FEBS Lett 458:45–50
Pedone PV, Tirabosco R, Cavazzana AO, Ungaro P, Basso G,
Luksch R, Carli M, et al (1994) Mono- and bi-allelic ex-
pression of insulin-like growth factor II gene in human mus-
cle tumors. Hum Mol Genet 7:1117–1121
Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Fein-
berg AP (1993) Relaxation of imprinted genes in human
cancer. Nature 362:747–749
Rechler MM, Nissley SP (1990) Insulin-like growth factors.
In: Sporn MB, Roberts AB (eds) Peptide growth factors and
their receptors. Springer-Verlag, New York, pp 263–368
Reik W, Maher ER (1997) Imprinting in clusters: lessons from
Beckwith-Wiedemann syndrome. Trends Genet 13:330–334
Smilinich NJ, Day CD, Fitzpatrick GV, Caldwell GM, Lossie
AC, Cooper PR, Smallwood AC, et al (1999) A maternally
methylated CpG island in KvLQT1 is associated with an
antisense paternal transcript and loss of imprinting in Beck-
with-Wiedemann syndrome. Proc Natl Acad Sci USA 96:
8064–8069
Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL, Fein-
berg AP (1994) Loss of imprinting of IGF2 is linked to
reduced expression and abnormal methylation of H19 in
Wilms’ tumour. Nat Genet 3:433–439
Sun FL, Dean WL, Kelsey G, Allen ND, Reik W (1997) Tran-
sactivation of Igf2 in a mouse model of Beckwith-Wiede-
mann syndrome. Nature 389:809–815
Tadokoro K, Fujii H, Inoue T, Yamada M (1991) Polymerase
chain reaction (PCR) for detection of ApaI polymorphism
at the insulin-like growth factor II gene (IGF2). Nucleic Ac-
ids Res 19:6967
Taniguchi T, Sullivan MJ, Ogawa O, Reeve AE (1995) Epi-
genetic changes encompassing the IGF2/H19 locus associ-
ated with relaxation of IGF2 imprinting and silencing of
H19 in Wilms tumor. Proc Natl Acad Sci USA 92:
2159–2163
Thorvaldsen JL, Duran KL, Bartolomei M (1998) Deletion of
the H19 differentially methylated domain results in loss of
imprinted expression of H19 and Igf2. Genes Dev 12:
3693–3702
Tilghman SM (1999) The sins of the fathers and mothers:
genomic imprinting in mammalian development. Cell 96:
185–193
Toretsky JA, Helman LJ (1996) Involvement of IGF-II in hu-
man cancer. J Endocrinol 149:367–372
Weaver DD (1994) Overgrowth syndromes and disorders: def-
inition, classification, and discussion. Growth Genet Horm
10:1–6
Weksberg R, Shem DR, Song QL, Squire J (1993) Disruption
of insulin-like growth factor 2 imprinting in Beckwith-Wie-
demann syndrome. Nat Genet 5:143–150
Whelan AJ, WatsonMS, Porter FD, Steiner RD (1995) Klippel-
Trenaunay-Weber syndrome associated with a 5:11 balanced
translocation. Am J Med Genet 59:492–494
Xu Y, Goodyer CG, Deal C, Polychronakos C (1993) Func-
tional polymorphism in the parental imprinting of the hu-
man IGF2R gene. Biochem Biophys Res Commun 197:
747–754
